Is this the end of rivaroxaban for acute VTE?
@LanaCastellucci presenting the COBBRA trial - 1st RCT comparing apixaban to riva over 3 months.
56% reduction in bleeding risk with apixaban.
A safer Rx with the same efficacy.
#ISTH2025
@ADSportsTV@a_ashkanani88 السلام عليكم، عندي اقتراح بوضع تسجيل للبرامج الخاصة باستديوهات الدوري الإيطالي الي تكون قبل وبعد كل جولة يكون متاح على منصة ستارز بلاي حتى يتنسى للجميع الاستمتاع بها في اي وقت، لان حاليا ��وجد فقط ملخصات المباريات، اتمنى النظر بالمقترح وشكرا.
Today, we finalized recommendations for assessing blood donor eligibility using a set of individual risk-based questions to reduce the risk of transfusion-transmitted HIV.
https://t.co/uVobgZqMeU
Today is World Thrombosis Day! Join us in raising awareness for the over looked and misunderstood condition of #thrombosis. We will be raising awareness for #WTDay21 all day today. What are you doing to raise awareness in your community?
Have you registered for #ISTH2020 yet? Don't miss your free opportunity to stay up to date on the latest in #thrombosis and #hemostasis from the comfort of your home computer. Register now at https://t.co/BwQsUQTUB0
Registration for the #ISTH2020 Virtual Congress is open! Join us on July 12-14 for the leading global congress on #thrombosis and #hemostasis. Register today at https://t.co/BwQsUQTUB0
❄️As we enter the winter months, #flu is likely to affect many across the WHO/Europe Region. Make sure you’re prepared this year by getting vaccinated #VaccinesWork